IV Chelation Therapy

Chelation therapy uses chelating agents such as EDTA to bind heavy metals and minerals in the bloodstream so they can be excreted through urine. It is used to reduce body burden of lead, mercury, cadmium, and arsenic. Some protocols also use chelation for cardiovascular support, which is an off-label application. Your provider reviews the regulatory status, available evidence, potential benefits, and known risks during informed consent before therapy begins.

Yes. Chelation is established as effective for binding and removing heavy metals including lead, mercury, cadmium, and arsenic. Before starting, the clinic typically tests your heavy metal levels to confirm meaningful exposure and establish a baseline, since treating without documented burden is not appropriate. Kidney function and essential mineral levels are checked before and during the course. You will receive specific guidance on hydration and mineral replacement throughout therapy.

EDTA chelation is FDA-approved for lead poisoning and certain acute heavy metal toxicities. Other applications, including cardiovascular protocols and general detoxification, are off-label and based on clinical judgment and research such as the TACT trial. Your provider will explain which category your therapy falls into, review the supporting evidence and its limitations, and complete informed consent before beginning. Chelation should never be used as a substitute for standard cardiovascular care.

Chelation is typically given as a slow IV infusion over one hour in a medical setting, since rapid administration can cause dangerous drops in calcium and blood pressure. Vital signs are monitored during each session, and kidney function and mineral levels are checked periodically throughout the course. The clinic starts with an initial series and adjusts dosing based on your labs, tolerance, and response rather than following a fixed protocol.

Possible effects include low blood pressure, depletion of essential minerals such as zinc and magnesium, kidney strain, vein irritation, and fatigue after sessions. Monitoring and scheduled mineral replacement help minimize these risks. Chelation is not appropriate for people with significant kidney disease, and rapid or improperly dosed EDTA administration has caused serious harm, which is why it must be performed under medical supervision. Candidacy is determined through consultation and baseline lab review.

Heavy metal protocols may require 10 to 30+ sessions, often given weekly, with repeat testing partway through to assess progress. Cardiovascular protocols follow different schedules, and the TACT trial protocol used 40 infusions. The clinic builds a plan based on your baseline levels, goals, and lab findings, then reassesses rather than committing to a fixed number upfront. Sessions are spaced to allow mineral repletion between therapies.

The TACT trial showed a modest benefit in some post-heart-attack patients with diabetes, but chelation remains off-label for cardiovascular disease and subsequent research has not settled the question. It should only be considered as part of a comprehensive cardiovascular plan under medical supervision, never as a replacement for statins, blood pressure management, or cardiology care. Individual results vary, and your provider will review the evidence and its limitations honestly during informed consent.

Kidney function is checked before therapy and monitored throughout the course, because chelating agents and the mobilized metals they carry are cleared renally. Chelation may not be appropriate for patients with significant kidney disease or reduced GFR. Adequate hydration before and after each session and appropriate mineral support are essential parts of safe chelation. If kidney markers shift during therapy, the protocol is paused or adjusted.

You may urinate more frequently for several hours as metals and minerals are excreted. Some patients feel tired afterward while others feel energized, and mild lightheadedness can occur if blood pressure drops. Mineral repletion is provided according to your provider’s guidance, typically including magnesium and zinc. Drinking plenty of water afterward is important. Progress is reviewed at follow-up visits with repeat testing so the plan can be adjusted.

No. The clinic does not bill insurance for any service, so chelation is self-pay. Most IV therapies here fall between $89 and $600 per session depending on the protocol. Because chelation typically requires a series, ask about multi-session pricing during your consultation, as meaningful discounts are available on courses of therapy. Baseline and follow-up testing for kidney function and mineral levels are separate costs worth factoring in.